Erythropoietin and tumor angiogenesis

Domenico Ribatti

Research output: Contribution to journalArticle

Abstract

Erythropoietin (Epo) may be considered as an endogenous stimulator of vessel growth during tumor progression through an autocrine and/or paracrine loop. The vascular effects of Epo would be relevant in tumor angiogenesis and the negative effect of Epo on tumor growth may be aggravated by its angiogenic activity. The mechanism of tumor growth in the context of Epo is not completely clarified, and it is still not clear whether there is a direct effect of Epo in tumor cells as opposed to exogenous effect on angiogenesis. It is also possible that the effect of Epo is multifactorial depending on the type of tumor and level of functionality of Epo receptor expression in tumor cells, as well other variables such as hypoxic stress, degree of anemia, chemotherapy, radiotherapy of surgical intervention.

Original languageEnglish
Pages (from-to)1-4
Number of pages4
JournalStem Cells and Development
Volume19
Issue number1
DOIs
Publication statusPublished - Jan 1 2010

Fingerprint

Erythropoietin
Neoplasms
Growth
Erythropoietin Receptors
Angiogenesis Inducing Agents
Blood Vessels
Anemia
Radiotherapy
Drug Therapy

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology
  • Hematology

Cite this

Erythropoietin and tumor angiogenesis. / Ribatti, Domenico.

In: Stem Cells and Development, Vol. 19, No. 1, 01.01.2010, p. 1-4.

Research output: Contribution to journalArticle

Ribatti, Domenico. / Erythropoietin and tumor angiogenesis. In: Stem Cells and Development. 2010 ; Vol. 19, No. 1. pp. 1-4.
@article{3b3aec79212c4d038490b07ed7fdc046,
title = "Erythropoietin and tumor angiogenesis",
abstract = "Erythropoietin (Epo) may be considered as an endogenous stimulator of vessel growth during tumor progression through an autocrine and/or paracrine loop. The vascular effects of Epo would be relevant in tumor angiogenesis and the negative effect of Epo on tumor growth may be aggravated by its angiogenic activity. The mechanism of tumor growth in the context of Epo is not completely clarified, and it is still not clear whether there is a direct effect of Epo in tumor cells as opposed to exogenous effect on angiogenesis. It is also possible that the effect of Epo is multifactorial depending on the type of tumor and level of functionality of Epo receptor expression in tumor cells, as well other variables such as hypoxic stress, degree of anemia, chemotherapy, radiotherapy of surgical intervention.",
author = "Domenico Ribatti",
year = "2010",
month = "1",
day = "1",
doi = "10.1089/scd.2009.0402",
language = "English",
volume = "19",
pages = "1--4",
journal = "Stem Cells and Development",
issn = "1547-3287",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Erythropoietin and tumor angiogenesis

AU - Ribatti, Domenico

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Erythropoietin (Epo) may be considered as an endogenous stimulator of vessel growth during tumor progression through an autocrine and/or paracrine loop. The vascular effects of Epo would be relevant in tumor angiogenesis and the negative effect of Epo on tumor growth may be aggravated by its angiogenic activity. The mechanism of tumor growth in the context of Epo is not completely clarified, and it is still not clear whether there is a direct effect of Epo in tumor cells as opposed to exogenous effect on angiogenesis. It is also possible that the effect of Epo is multifactorial depending on the type of tumor and level of functionality of Epo receptor expression in tumor cells, as well other variables such as hypoxic stress, degree of anemia, chemotherapy, radiotherapy of surgical intervention.

AB - Erythropoietin (Epo) may be considered as an endogenous stimulator of vessel growth during tumor progression through an autocrine and/or paracrine loop. The vascular effects of Epo would be relevant in tumor angiogenesis and the negative effect of Epo on tumor growth may be aggravated by its angiogenic activity. The mechanism of tumor growth in the context of Epo is not completely clarified, and it is still not clear whether there is a direct effect of Epo in tumor cells as opposed to exogenous effect on angiogenesis. It is also possible that the effect of Epo is multifactorial depending on the type of tumor and level of functionality of Epo receptor expression in tumor cells, as well other variables such as hypoxic stress, degree of anemia, chemotherapy, radiotherapy of surgical intervention.

UR - http://www.scopus.com/inward/record.url?scp=75749155778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75749155778&partnerID=8YFLogxK

U2 - 10.1089/scd.2009.0402

DO - 10.1089/scd.2009.0402

M3 - Article

C2 - 19886790

AN - SCOPUS:75749155778

VL - 19

SP - 1

EP - 4

JO - Stem Cells and Development

JF - Stem Cells and Development

SN - 1547-3287

IS - 1

ER -